Synthesis and Study of Novel Sensing Agents
Synthesis and Study of Novel Sensing Agents
批准号:
7568898
负责人:
ROBERT M STRONGIN
金额:
$25.82万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-05-01 至 2011-03-31
关键词:
AcetylcysteineAcidsAddressAdvisory CommitteesAldehydesAlzheimer&aposs disease riskAmericanAmidesAmino AcidsAwardBiologicalBiological MarkersBiomedical ResearchBlood CirculationCarbonCardiovascular DiseasesCenters for Disease Control and Prevention (U.S.)Cessation of lifeChemistryComplexCysteineDNA Sequence RearrangementDetectionDevelopmentDiagnosisDietDiseaseEquilibriumEtiologyEuropeanExhibitsFlourFluorescenceFolic AcidFood SupplyFree RadicalsGangliosidesGeneticGlutathioneGoalsHeartHigh temperature of physical objectHomocysteineHomocystineHomocystinuriaHumanHydrogen BondingHyperhomocysteinemiaInborn Genetic DiseasesInflammatory Bowel DiseasesKnowledgeLeadLeftLinkLysineMethionine Metabolism PathwayMethodsMonitorMonosaccharidesMyocardial InfarctionNerve DegenerationNeural Tube DefectsNutritionalOligosaccharidesOrganic ChemistryOsteoporosisOxidantsOxidation-ReductionPaperPathologyPatientsPenicillaminePharmaceutical PreparationsPlant RootsPlasmaPopulation StudyPost-Translational Protein ProcessingPregnancyPreventionProtein BindingProtein ChemistryProteinsProtocols documentationReactionRecording of previous eventsReducing AgentsResearchResearch PersonnelRiskRoleSchemeServicesSourceSpecificityStrokeStructureSulfhydryl CompoundsSulfurTestingThromboembolismTimeVenousVisualVitamin B 12 DeficiencyVitaminsWorkaminothiolbasecardiovascular risk factordesigndisorder riskfortificationhigh riskimmunogenicimprovedinsightinstrumentationlifestyle factorsnovelpreventprogramsprotein Mxtoolvitamin therapy
中文摘要
描述(由申请人提供):该更新申请是通过设计具有高分析物特异性的合成有机指示剂,在可见光谱区域检测无色生物分子的继续努力。该计划的广泛和长期目标是通过为生物医学研究创造实用的新工具来促进疾病的诊断和理解。血浆同型半胱氨酸(Hcy)水平升高与心肌梗死、中风和静脉血栓栓塞的风险增加有关。同型半胱氨酸还与阿尔茨海默病、神经管缺陷和妊娠并发症、炎症性肠病和骨质疏松症的风险增加有关。尽管经过20多年的深入研究,同型半胱氨酸在疾病中的实际作用仍不清楚。目标是有助于(i)澄清目前对同型半胱氨酸在疾病中的作用的理解,以及(ii)促进对天然培养基中同型半胱氨酸的研究。解决这两个问题的方法根植于基本的有机化学。揭示Hcy与其他硫醇和生物分子之间基本有机化学的差异将提供与Hcy参与疾病相关的新知识,同时导致高选择性和使能的新检测方法。为实现这些目标,提出了以下具体目标:目标1。简化同型半胱氨酸测定的高选择性指标。目标2。对同型半胱氨酸衍生的α -氨基碳中心自由基化学的新见解。目标3。蛋白结合同型半胱胺的检测与化学。该项目的每个具体目标都涉及改进同型半胱氨酸的检测。同型半胱氨酸在人体中高于一定水平通常表明有严重的疾病风险。这种有用的氨基酸生物标志物已经研究了几十年,但它在疾病中的作用仍然不清楚。我们建议创造更简单的新方法和新材料来检测同型半胱氨酸,并澄清其在疾病中的作用。
英文摘要
DESCRIPTION (provided by applicant): This renewal application is a continuation of efforts to detect colorless biomolecules in the visible spectral region by designing synthetic organic indicators with high analyte specificity. The broad, long-term objective of this program is to facilitate the diagnosis and understanding of disease via the creation of practical new tools for biomedical research. Elevated plasma homocysteine (Hcy) levels are associated with increased risk of myocardial infarction, stroke and venous thromboembolism. Homocysteine has also been linked to increased risk of Alzheimer's disease, neural tube defects and complications during pregnancy, inflammatory bowel disease and osteoporosis. Despite over 20 years of intense study, the actual role of homocysteine in disease remains unclear. The goals are to contribute to (i) clarifying the current understanding of the role of homocysteine in disease and (ii) facilitate the study homocysteine in natural media. The approach to these two issues is rooted in fundamental organic chemistry. Uncovering the differences in the basic organic chemistry between Hcy and other thiols and biomolecules will afford new knowledge relevant to Hcy's involvement in disease and concurrently lead to highly selective and enabling new detection methods. To approach these goals, the following Specific Aims are proposed: Aim 1. Highly selective indicators for simplifying the determination of homocysteine. Aim 2. New insights into the chemistry of the homocysteine-derived alpha-amino carbon-centered radical. Aim 3. Detection and chemistry of protein-bound homocystamide. Each of the Specific Aims of this project involves improving the detection of homocysteine. The presence of homocysteine above certain levels in humans often indicates serious risk for disease. This useful amino acid biomarker has been studied for decades, but its role in disease is still not clear. We propose to create simpler new methods and materials for homocysteine detection as well as clarification of its role in disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Toxicant Production and Mitigation in the Electronic-Cigarette Reaction Vessel
-
批准号:9560821
-
项目类别:
-
资助金额:$71.87万
-
财政年份:2015
-
负责人:ROBERT M STRONGIN
-
依托单位:
Toxicant Production and Mitigation in the Electronic-Cigarette Reaction Vessel
-
批准号:9306920
-
项目类别:
-
资助金额:$72.09万
-
财政年份:2015
-
负责人:ROBERT M STRONGIN
-
依托单位:
Toxicant Production and Mitigation in the Electronic-Cigarette Reaction Vessel
-
批准号:8874702
-
项目类别:
-
资助金额:$68.69万
-
财政年份:2015
-
负责人:ROBERT M STRONGIN
-
依托单位:
A Simple and Robust Indicator for Glutathione
-
批准号:8627059
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2014
-
负责人:ROBERT M STRONGIN
-
依托单位:
MBRS IMSD Program at Louisiana State University
-
批准号:6863719
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2004
-
负责人:ROBERT M STRONGIN
-
依托单位:
MBRS IMSD Program
-
批准号:6711902
-
项目类别:
-
资助金额:$17.43万
-
财政年份:2004
-
负责人:ROBERT M STRONGIN
-
依托单位:
MBRS IMSD Program at Louisiana State University
-
批准号:7036580
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:ROBERT M STRONGIN
-
依托单位:
SYNTHESIS OF INHIBITORS OF BIOTIN CARBOXYLASE
-
批准号:6665891
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:6332294
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:6520327
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:6747714
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:6636510
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:7264268
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:7795818
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
SYNTHESIS OF INHIBITORS OF BIOTIN CARBOXYLASE
-
批准号:6486771
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
Synthesis and Study of Novel Sensing Agents
-
批准号:6886743
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2001
-
负责人:ROBERT M STRONGIN
-
依托单位:
SYNTHESIS OF INHIBITORS OF BIOTIN CARBOXYLASE
-
批准号:6336841
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2000
-
负责人:ROBERT M STRONGIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: